why choose us

First received: January 04, 2024

Clinical Trial: Effect of Extended Release Torsemide in Patients With Congestive Heart Failure and Overactive Bladder

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Heart Failure

Study Type: INTERVENTIONAL


Official Title: A Crossover, Double-blinded, Two-period, Double Dummy Study to Evaluate the Effects of Extended Release Torsemide in Patients With Chronic Congestive Heart Failure and Symptoms of Overactive Bladder

Brief Summary: This research study is being done to compare the effectiveness two drugs: an Extended Release Torsemide (ERT) versus generic Immediate Release Torsemide (IRT) in reducing the worsening of symptoms of Overactive Bladder (OAB, i.e., frequency, urgency, or urgency incontinence) in patients with chronic congestive heart failure (CHF).This study will include CHF patients who experience worsening (OAB) symptoms with use of a loop diuretic.The total duration of the study is about eight weeks with a total of nine…

Read more